接受维持性透析患者对SARS-CoV-2疫苗第三剂的血清反应。 - Suppr

Suppr

超能文献

Seroresponse to Third Doses of SARS-CoV-2 Vaccine Among Patients Receiving Maintenance Dialysis.

作者信息

Hsu Caroline M, Lacson Eduardo K, Manley Harold J, Aweh Gideon N, Miskulin Dana, Johnson Doug, Weiner Daniel E

机构信息

Tufts Medical Center, Boston, Massachusetts.

Tufts Medical Center, Boston, Massachusetts; Dialysis Clinic, Inc., Nashville, Tennessee.

出版信息

Am J Kidney Dis. 2022 Jul;80(1):151-153. doi: 10.1053/j.ajkd.2022.03.002. Epub 2022 Apr 1.

DOI:10.1053/j.ajkd.2022.03.002

PMID:35378208

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8972976/

Abstract

摘要

相似文献

Seroresponse to Third Doses of SARS-CoV-2 Vaccine Among Patients Receiving Maintenance Dialysis.接受维持性透析患者对SARS-CoV-2疫苗第三剂的血清反应。

Am J Kidney Dis. 2022 Jul;80(1):151-153. doi: 10.1053/j.ajkd.2022.03.002. Epub 2022 Apr 1.

Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.维持性透析患者接种 SARS-CoV-2 疫苗后 6 个月的血清学反应。

Clin J Am Soc Nephrol. 2022 Mar;17(3):403-413. doi: 10.2215/CJN.12250921. Epub 2022 Feb 10.

Seroresponse to SARS-CoV-2 Vaccines Among Maintenance Dialysis Patients.维持性透析患者对SARS-CoV-2疫苗的血清反应。

Am J Kidney Dis. 2022 Feb;79(2):307-310. doi: 10.1053/j.ajkd.2021.10.002. Epub 2021 Nov 7.

SARS-CoV-2 Booster Vaccine Response among Patients Receiving Dialysis.接受透析患者的新型冠状病毒2型加强疫苗反应

Clin J Am Soc Nephrol. 2022 Jul;17(7):1036-1038. doi: 10.2215/CJN.00890122. Epub 2022 Apr 5.

Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.一种自我扩增 RNA COVID-19 疫苗（ARCT-154）与 BNT162b2 mRNA COVID-19 疫苗加强针的免疫原性和安全性：一项双盲、多中心、随机、对照、3 期、非劣效性试验。

Lancet Infect Dis. 2024 Apr;24(4):351-360. doi: 10.1016/S1473-3099(23)00650-3. Epub 2023 Dec 20.

SARS-CoV-2 Infection during the Omicron Surge among Patients Receiving Dialysis: The Role of Circulating Receptor-Binding Domain Antibodies and Vaccine Doses.奥密克戎变异株流行期间接受透析治疗患者的 SARS-CoV-2 感染：循环受体结合域抗体和疫苗剂量的作用。

J Am Soc Nephrol. 2022 Oct;33(10):1832-1839. doi: 10.1681/ASN.2022040504. Epub 2022 Aug 16.

Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse.接种疫苗的透析患者中SARS-CoV-2抗体滴度的系列研究：未识别感染的患病率和血清反应持续时间

Kidney Med. 2023 Aug 25;5(11):100718. doi: 10.1016/j.xkme.2023.100718. eCollection 2023 Nov.

Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients.透析患者接种 BNT162b2 疫苗第三剂和第四剂后体液免疫反应和 SARS-CoV-2 感染风险。

Am J Nephrol. 2022;53(7):586-590. doi: 10.1159/000525309. Epub 2022 Jul 18.

High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients.mRNA 疫苗对慢性透析患者 SARS-CoV-2 具有高免疫原性。

Nephrol Dial Transplant. 2021 Aug 27;36(9):1704-1709. doi: 10.1093/ndt/gfab193.

BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis Patients.BNT162b2 与 mRNA-1273 序贯加强 COVID-19 疫苗在慢性肾脏病及维持性透析患者中的应用。

Clin J Am Soc Nephrol. 2024 Jan 1;19(1):85-97. doi: 10.2215/CJN.0000000000000328. Epub 2023 Oct 17.

引用本文的文献

COVID-19 Hospitalization and Mortality Trends Among US Dialysis Patients by Race/Ethnicity and Vaccination Status.按种族/民族和疫苗接种状况划分的美国透析患者中新冠病毒肺炎住院和死亡趋势

Kidney Med. 2025 May 16;7(7):101026. doi: 10.1016/j.xkme.2025.101026. eCollection 2025 Jul.

Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients.实体器官移植成年候选者及受者的疫苗接种建议

Vaccines (Basel). 2023 Oct 18;11(10):1611. doi: 10.3390/vaccines11101611.

Kidney Med. 2023 Aug 25;5(11):100718. doi: 10.1016/j.xkme.2023.100718. eCollection 2023 Nov.

From past to present: Exploring COVID-19 in Qatar's hemodialysis population across Omicron dominant and pre-Omicron periods.从过去到现在：探索卡塔尔血液透析人群中奥密克戎主导和奥密克戎前时期的 COVID-19 情况。

PLoS One. 2023 Sep 14;18(9):e0291266. doi: 10.1371/journal.pone.0291266. eCollection 2023.

The impact of Omicron on outcomes following infection with SARS-CoV-2 in patients with kidney failure in Scotland.奥密克戎对苏格兰肾衰竭患者感染新冠病毒后预后的影响。

Clin Kidney J. 2022 Jul 23;16(1):197-200. doi: 10.1093/ckj/sfac173. eCollection 2023 Jan.

Humoral response after SARS-CoV-2 booster vaccination in haemodialysis patients with and without prior infection.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）加强疫苗接种后，有或无既往感染的血液透析患者的体液免疫反应

Clin Kidney J. 2022 May 24;15(8):1633-1635. doi: 10.1093/ckj/sfac148. eCollection 2022 Aug.

本文引用的文献

SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance Dialysis.维持性透析患者中 SARS-CoV-2 疫苗有效性和突破性感染。

Am J Kidney Dis. 2023 Apr;81(4):406-415. doi: 10.1053/j.ajkd.2022.10.010. Epub 2022 Dec 1.

Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.维持性透析患者接种 SARS-CoV-2 疫苗后 6 个月的血清学反应。

Clin J Am Soc Nephrol. 2022 Mar;17(3):403-413. doi: 10.2215/CJN.12250921. Epub 2022 Feb 10.

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel.接种 BNT162b2 可降低以色列家庭接触者中 SARS-CoV-2 的传播。

Science. 2022 Mar 11;375(6585):1151-1154. doi: 10.1126/science.abl4292. Epub 2022 Jan 27.

Tixagevimab and Cilgavimab (Evusheld) for Pre-Exposure Prophylaxis of COVID-19.替沙格韦单抗和西加韦单抗（恩适得）用于新型冠状病毒肺炎暴露前预防

JAMA. 2022 Jan 25;327(4):384-385. doi: 10.1001/jama.2021.24931.

Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series.肾移植受者对第四剂信使核糖核酸新冠疫苗的抗体反应：病例系列

Ann Intern Med. 2022 Mar;175(3):455-456. doi: 10.7326/L21-0598. Epub 2022 Jan 11.

Secondary Immunodeficiency Related to Kidney Disease (SIDKD)-Definition, Unmet Need, and Mechanisms.与肾脏病相关的继发性免疫缺陷 (SIDKD)-定义、未满足的需求和机制。

J Am Soc Nephrol. 2022 Feb;33(2):259-278. doi: 10.1681/ASN.2021091257. Epub 2021 Dec 14.

Seroresponse to SARS-CoV-2 Vaccines Among Maintenance Dialysis Patients.维持性透析患者对SARS-CoV-2疫苗的血清反应。

Am J Kidney Dis. 2022 Feb;79(2):307-310. doi: 10.1053/j.ajkd.2021.10.002. Epub 2021 Nov 7.

Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis.维持性血液透析患者对第三次注射BNT162b2疫苗的体液反应。

Clin Kidney J. 2021 Aug 13;14(11):2349-2355. doi: 10.1093/ckj/sfab152. eCollection 2021 Nov.

SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.维持性血液透析或腹膜透析患者接种第三剂 BNT162b2 疫苗后的 SARS-CoV-2 抗体反应。

Am J Kidney Dis. 2022 Feb;79(2):185-192.e1. doi: 10.1053/j.ajkd.2021.08.005. Epub 2021 Sep 8.

COVID-19 vaccination in haemodialysis patients: good things come in threes….血液透析患者的新冠病毒疫苗接种：好事成三……

Nephrol Dial Transplant. 2021 Sep 27;36(10):1947-1949. doi: 10.1093/ndt/gfab224.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验